GGrantIndex
← Search

Population Studies

$144,861P30FY2013CANIH

Research Inst Of Fox Chase Can Ctr, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 39604567Paper 39602533Paper 39554190Paper 39546469Paper 39521739Paper 39514554Paper 39371220Paper 39345610Paper 39343653Paper 39223207Paper 39207123Paper 39189642Paper 39148468Paper 39137728Paper 39072643Paper 39060143Paper 39013784Paper 39003201Paper 38982062Paper 38976159Paper 38963567Paper 38914477Paper 38871720Paper 38865671Paper 38853421Paper 38835516Paper 38815457Paper 38811332Paper 38798370Paper 38766032Paper 38747616Paper 38678525Paper 38659828Paper 38639476Paper 38638131Paper 38600381Paper 38586274Paper 38586042Paper 38559274Paper 38547779Paper 38539515Paper 38464238Paper 38452871Paper 38432028Paper 38421650Paper 38377387Trial NCT04290585Trial NCT03177057Trial NCT02594826Trial NCT02132884Trial NCT02132858Trial NCT02132845Trial NCT02110953Trial NCT02092714Trial NCT02050009Trial NCT01982591Trial NCT01962948Trial NCT01934179Trial NCT01840150Trial NCT01462630Trial NCT01316757Trial NCT01212822Trial NCT00750009Trial NCT00509626Trial NCT00458588Trial NCT00436397Trial NCT00433524Trial NCT00084591Trial NCT00084539Trial NCT00084526Trial NCT00084513Trial NCT00066677Trial NCT00062322Trial NCT00062309Trial NCT00043108Trial NCT00039520Trial NCT00039507Trial NCT00022308Trial NCT00021398Trial NCT00021372Trial NCT00021346Trial NCT00021333Trial NCT00021320Trial NCT00005037Trial NCT00003264Trial NCT00003263Trial NCT00003109Patent 9533040Patent 9182383Patent 9101603Patent 8980258Patent 8685658Patent 8609437Patent 8580263Patent 8329873Patent 7332585Patent 7332580Patent 7129057Patent 6946275Patent 6617427

Abstract

Many Fox Chase Cancer Center (FCCC) studies, including those in cancer control and prevention, translational research, human genetics, behavioral medicine and some animal trials employ a variety of designs that are substantially more complex than typical cancer clinical trials. These investigations require development of study-specific information systems for project management, and the collection, validation, storage, and retrieval of data. The Population Studies Facility (PSF) facilitates research conducted by FCCC peer-reviewed, funded investigators by providing access to a team of information systems professionals with experience in state-of-the-art software engineering applied to cancer research. The PSF functions include development of; databases for the storage and manipulation of large quantities of questionnaire, clinical, molecular and specimen data; electronic data entry and retrieval systems; report generation software; consistency and quality control systems; and systems that provide integration and controlled exchange of data from diverse sources. For example, the system developed by the PSF for the Breast Cancer Family Registry study provides for the entry, coordination and retrieval of longitudinal information, specimen inventory, genetic testing, and complex pedigree data. The PSF also provides systems that facilitate the peer-reviewed, funded investigator support activities of many CCSG-supported cores. The PSF has developed information systems that maintain data on over 180,000 subjects. Of these, more than 60,000 were enrolled in FCCC studies within the US; the remainder participated in several international cohort studies. The PSF provided services to 54 peer-reviewed, funded investigators in all five Programs and 129 projects over the last five years. These represent 35% and 6 1% increases in the number of supported investigators and projects, respectively, over the previous funding cycle. Improved application development efficiency provided by the PSF's creation of the Population Research Application Generation Environment (PRESAGE) toolset and the use of open source solutions has allowed the PSF to accommodate the increase in demand for informatics services with only a 9% increase in staffing. The PSF made contributions to 100 manuscripts and PSF personnel have appeared as co-authors on 47 publications over the current funding period. It has a user charge back system that, combined with other direct grant funding, recoups 74% of its operating cost. In 2009, 66.2% of its use was directly for peer-reviewed, funded investigators. This Facility was rated Outstanding during the last review.

View original record on NIH RePORTER →
Population Studies · GrantIndex